Company Name: ProQR Therapeutics N.V.

ProQR Therapeutics N.V. is a biopharmaceutical company. The company is engaged in the development of RNA-based medicines for severe genetic disorders. The company’s lead product candidate is a therapy for cystic fibrosis.  

Ticker Symbol: PRQR (NASDAQ)

Company Websitewww.proqr.com

Social Media: ProQR Therapeutics LinkedIn

Headquarters: Leiden, The Netherlands